Our broad-based transaction experience extends across a range of situations, industries and enterprise values
Categories
Year
Type
Industry
Announced: March 7, 2025Value: $26.1 billionStatus: PendingExclusive financial advisor to Walgreens Boots Alliance on the take-private transaction of WBA by Sycamore Partners
Announced: January 27, 2025Value: $16.8 billionStatus: PendingFinancial advisor to Emerson on its acquisition of AspenTech
Announced: January 13, 2025Value: $14.6 billionStatus: PendingCenterview acted as lead financial advisor to Intra-Cellular on its sale to Johnson & Johnson
Announced: January 13, 2025Value: Up to $2.5 billionStatus: PendingCenterview acted as lead financial advisor to Scorpion on its sale to Eli Lilly
Announced: March 17, 2025Value: $1.95 billionStatus: PendingLead financial advisor to PepsiCo on its acquisition of poppi
Announced: February 20, 2025Value: $1.8 billionStatus: PendingFinancial advisor to certain Alani Nu shareholders
Announced: January 14, 2025Value: $1.78 billionStatus: PendingCenterview served as lead financial advisor to Bain Capital and Evident in their sale of Evident's Inspection Technologies division to Wabtec
Announced: January 13, 2025Value: Up to $1.15 billionStatus: PendingExclusive advisor to IDRx on its sale to GSK
Announced: March 17, 2025Value: Up to $1.1 billionStatus: PendingExclusive financial advisor to Araris on its acquisition by Taiho Pharmaceutical, a subsidiary of Otsuka Holdings
Announced: March 17, 2025Value: Up to $1.0 billionStatus: PendingExclusive financial advisor to EsoBiotec on its acquisition by AstraZeneca
Announced: January 28, 2025Value: Up to $1.0 billionStatus: PendingExclusive financial advisor to Evergreen on its sale to Lantheus
Announced: January 8, 2025Value: Up to $900 millionStatus: PendingExclusive advisor to Bolt on its sale to Boston Scientific
Announced: January 8, 2025Value: $795 millionStatus: PendingServed as financial advisor to Simple Mills on its sale to Flowers Foods
Announced: February 25, 2025Value: $300 millionStatus: PendingExclusive financial advisor to ChampionX in its divestiture of US Synthetic to LongRange Capital
Announced: January 29, 2025Value: $250 millionStatus: PendingExclusive financial advisor to Henry Schein in its strategic investment by KKR and board change
Announced: March 12, 2025Status: ClosedFinancial advisor to Zealand Pharma on its global collaboration and license agreement with Roche
Announced: March 5, 2025Value: $935mmStatus: PendingExclusive financial advisor to Chimerix on its sale to Jazz Pharmaceuticals
Announced: March 5, 2025Status: PendingExclusive investment banker and financial advisor to the Ad Hoc Group of Cutera's convertible note holders in its filing for chapter 11 and subsequent comprehensive restructuring transaction
Announced: March 4, 2025Status: PendingSole financial advisor to Repligen on its acquisition of 908 Devices' Bioprocessing PAT portfolio
Announced: February 28, 2025Status: PendingFinancial advisor to Apax on its strategic investment in ECI Software Solutions
Announced: February 27, 2025Status: PendingSole financial advisor to Teleflex on its separation transaction and strategic advisor to the company on its value creation framework
Announced: February 6, 2025Status: PendingFinancial advisor to Honeywell on the separation of its Automation and Aerospace businesses into two separate public companies
Announced: January 22, 2025Status: PendingFinancial advisor to Aptiv on its plan to spin-off its Electrical Distribution Systems business
Announced: January 15, 2025Status: PendingExclusive investment banker to JOANN in its filing for chapter 11 bankruptcy
Announced: January 8, 2025Status: PendingExclusive financial advisor to Alacrity on its strategic transaction for long-term growth
Announced: January 6, 2025Status: PendingFinancial advisor to Advent International on its acquisition of Sauer Brands
Announced: January 6, 2025Status: PendingExclusive financial advisor to The Walt Disney Company in its combination of Hulu and its live TV business with Fubo